Global Onychomycosis (Tinea Unguium) Drug Competitive Landscape Professional Research Report 2024
Description
Global Onychomycosis (Tinea Unguium) Drug Competitive Landscape Professional Research Report 2024
Research Summary
Onychomycosis, also known as tinea unguium, refers to a fungal infection of the nails, most commonly affecting the toenails but can also affect the fingernails. Onychomycosis drugs, or antifungal medications, are used to treat and manage this condition. These drugs can be administered orally, topically, or through a combination of both, depending on the severity of the infection. They work by inhibiting the growth of the fungi responsible for the nail infection, ultimately leading to the elimination of the fungal presence and the restoration of healthy nail growth. Onychomycosis drugs play a crucial role in addressing a common and often persistent condition that can impact the appearance and health of the nails, and they are typically prescribed and monitored by healthcare professionals.
According to DIResearch's in-depth investigation and research, the global Onychomycosis (Tinea Unguium) Drug market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.
The major global manufacturers of Onychomycosis (Tinea Unguium) Drug include Pfizer, Yangtze River, Johnson & Johnson, Torrent Pharma, Chengdu Brilliant, Novartis, Qilu Pharmaceutical, Xiuzheng Pharmaceutical, Hubei Hengan, TARO, Perrigo, Galderma pharm, Zhejiang Deyer, Valeant Pharma, Moberg etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Onychomycosis (Tinea Unguium) Drug. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Onychomycosis (Tinea Unguium) Drug market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Onychomycosis (Tinea Unguium) Drug market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Onychomycosis (Tinea Unguium) Drug industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Onychomycosis (Tinea Unguium) Drug Include:
Pfizer
Yangtze River
Johnson & Johnson
Torrent Pharma
Chengdu Brilliant
Novartis
Qilu Pharmaceutical
Xiuzheng Pharmaceutical
Hubei Hengan
TARO
Perrigo
Galderma pharm
Zhejiang Deyer
Valeant Pharma
Moberg
Onychomycosis (Tinea Unguium) Drug Product Segment Include:
Oral Drug
External Drug
Onychomycosis (Tinea Unguium) Drug Product Application Include:
Age under 18
Age 18-50
Age above 50
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Onychomycosis (Tinea Unguium) Drug Industry PESTEL Analysis
Chapter 3: Global Onychomycosis (Tinea Unguium) Drug Industry Porter’s Five Forces Analysis
Chapter 4: Global Onychomycosis (Tinea Unguium) Drug Major Regional Market Size and Forecast Analysis
Chapter 5: Global Onychomycosis (Tinea Unguium) Drug Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Onychomycosis (Tinea Unguium) Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Onychomycosis (Tinea Unguium) Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Onychomycosis (Tinea Unguium) Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Onychomycosis (Tinea Unguium) Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Onychomycosis (Tinea Unguium) Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Onychomycosis (Tinea Unguium) Drug Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Onychomycosis (Tinea Unguium) Drug Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Onychomycosis (Tinea Unguium) Drug Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Onychomycosis (Tinea Unguium) Drug Product by Type
- 1.2.1 Global Onychomycosis (Tinea Unguium) Drug Market Size by Type, 2023 VS 2024 VS 2030
- 1.2.2 Oral Drug
- 1.2.3 External Drug
- 1.3 Onychomycosis (Tinea Unguium) Drug Product by Application
- 1.3.1 Global Onychomycosis (Tinea Unguium) Drug Market Size by Application, 2023 VS 2024 VS 2030
- 1.3.2 Age under 18
- 1.3.3 Age 18-50
- 1.3.4 Age above 50
- 1.4 Global Onychomycosis (Tinea Unguium) Drug Market Revenue Analysis (2019-2030)
- 1.5 Onychomycosis (Tinea Unguium) Drug Market Development Status and Trends
- 1.5.1 Onychomycosis (Tinea Unguium) Drug Industry Development Status Analysis
- 1.5.2 Onychomycosis (Tinea Unguium) Drug Industry Development Trends Analysis
- 2 Onychomycosis (Tinea Unguium) Drug Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Onychomycosis (Tinea Unguium) Drug Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Onychomycosis (Tinea Unguium) Drug Market Analysis by Regions
- 4.1 Onychomycosis (Tinea Unguium) Drug Overall Market: 2023 VS 2024 VS 2030
- 4.2 Global Onychomycosis (Tinea Unguium) Drug Revenue and Forecast Analysis (2019-2030)
- 4.2.1 Global Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Region (2019-2024)
- 4.2.2 Global Onychomycosis (Tinea Unguium) Drug Revenue Forecast by Region (2025-2030)
- 5 Global Onychomycosis (Tinea Unguium) Drug Market Size by Type and Application
- 5.1 Global Onychomycosis (Tinea Unguium) Drug Market Size by Type
- 5.2 Global Onychomycosis (Tinea Unguium) Drug Market Size by Application
- 6 North America
- 6.1 North America Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate Analysis (2019-2030)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Onychomycosis (Tinea Unguium) Drug Market Size by Type
- 6.4 North America Onychomycosis (Tinea Unguium) Drug Market Size by Application
- 6.5 North America Onychomycosis (Tinea Unguium) Drug Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate Analysis (2019-2030)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Onychomycosis (Tinea Unguium) Drug Market Size by Type
- 7.4 Europe Onychomycosis (Tinea Unguium) Drug Market Size by Application
- 7.5 Europe Onychomycosis (Tinea Unguium) Drug Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate Analysis (2019-2030)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Onychomycosis (Tinea Unguium) Drug Market Size by Type
- 8.4 China Onychomycosis (Tinea Unguium) Drug Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate Analysis (2019-2030)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Onychomycosis (Tinea Unguium) Drug Market Size by Type
- 9.4 APAC (excl. China) Onychomycosis (Tinea Unguium) Drug Market Size by Application
- 9.5 APAC (excl. China) Onychomycosis (Tinea Unguium) Drug Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Indonesia
- 9.5.6 Vietnam
- 9.5.7 Malaysia
- 9.5.8 Thailand
- 10 Latin America
- 10.1 Latin America Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate Analysis (2019-2030)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Onychomycosis (Tinea Unguium) Drug Market Size by Type
- 10.4 Latin America Onychomycosis (Tinea Unguium) Drug Market Size by Application
- 10.5 Latin America Onychomycosis (Tinea Unguium) Drug Market Size by Country
- 10.5.1 Mecixo
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size and Growth Rate Analysis (2019-2030)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size by Type
- 11.4 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size by Application
- 11.5 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Market Competition by Manufacturers
- 12.1 Global Onychomycosis (Tinea Unguium) Drug Market Revenue by Key Manufacturers (2020-2024)
- 12.2 Onychomycosis (Tinea Unguium) Drug Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Onychomycosis (Tinea Unguium) Drug Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Pfizer
- 13.1.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Pfizer Onychomycosis (Tinea Unguium) Drug Product Portfolio
- 13.1.3 Pfizer Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.2 Yangtze River
- 13.2.1 Yangtze River Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Yangtze River Onychomycosis (Tinea Unguium) Drug Product Portfolio
- 13.2.3 Yangtze River Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.3 Johnson & Johnson
- 13.3.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Johnson & Johnson Onychomycosis (Tinea Unguium) Drug Product Portfolio
- 13.3.3 Johnson & Johnson Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.4 Torrent Pharma
- 13.4.1 Torrent Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Torrent Pharma Onychomycosis (Tinea Unguium) Drug Product Portfolio
- 13.4.3 Torrent Pharma Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.5 Chengdu Brilliant
- 13.5.1 Chengdu Brilliant Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Product Portfolio
- 13.5.3 Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.6 Novartis
- 13.6.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Novartis Onychomycosis (Tinea Unguium) Drug Product Portfolio
- 13.6.3 Novartis Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.7 Qilu Pharmaceutical
- 13.7.1 Qilu Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Portfolio
- 13.7.3 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.8 Xiuzheng Pharmaceutical
- 13.8.1 Xiuzheng Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Portfolio
- 13.8.3 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.9 Hubei Hengan
- 13.9.1 Hubei Hengan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Hubei Hengan Onychomycosis (Tinea Unguium) Drug Product Portfolio
- 13.9.3 Hubei Hengan Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.10 TARO
- 13.10.1 TARO Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 TARO Onychomycosis (Tinea Unguium) Drug Product Portfolio
- 13.10.3 TARO Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.11 Perrigo
- 13.11.1 Perrigo Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 Perrigo Onychomycosis (Tinea Unguium) Drug Product Portfolio
- 13.11.3 Perrigo Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.12 Galderma pharm
- 13.12.1 Galderma pharm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 Galderma pharm Onychomycosis (Tinea Unguium) Drug Product Portfolio
- 13.12.3 Galderma pharm Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.13 Zhejiang Deyer
- 13.13.1 Zhejiang Deyer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.13.2 Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Product Portfolio
- 13.13.3 Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.14 Valeant Pharma
- 13.14.1 Valeant Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.14.2 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Product Portfolio
- 13.14.3 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.15 Moberg
- 13.15.1 Moberg Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.15.2 Moberg Onychomycosis (Tinea Unguium) Drug Product Portfolio
- 13.15.3 Moberg Onychomycosis (Tinea Unguium) Drug Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 14 Industry Chain Analysis
- 14.1 Onychomycosis (Tinea Unguium) Drug Industry Chain Analysis
- 14.2 Onychomycosis (Tinea Unguium) Drug Industry Raw Material and Suppliers Analysis
- 14.2.1 Upstream Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Onychomycosis (Tinea Unguium) Drug Typical Downstream Customers
- 14.4 Onychomycosis (Tinea Unguium) Drug Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
